Axe Compute

Axe Compute ROIC

The Return on Invested Capital (ROIC) of Axe Compute (AGPU) as of Oct 29, 2026 is -472.01 %. In the previous year, Return on Invested Capital (ROIC) was -632.72 % — a change of -25.40% (higher).

ROIC

-472.01 %

YoY

-25.40%

Last updated:

Return on Invested Capital (ROIC) of Axe Compute is 2025 -472.01 % . Return on Invested Capital (ROIC) of Axe Compute was 2024 -632.72 % . It decreases by -25.40% higher compared to the previous year.

The Axe Compute ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
-597.40 USD
Jan 1, 2019
-112.63 USD
Jan 1, 2020
-303.91 USD
Jan 1, 2021
-47.78 USD
Jan 1, 2022
-117.28 USD
Jan 1, 2023
-127.15 USD
Jan 1, 2024
-632.72 USD
Jan 1, 2025
-472.01 USD
The Axe Compute ROIC history
YEARROICYoY
-472.01 %-25.40%
-632.72 %+397.62%
-127.15 %+8.42%
-117.28 %+145.47%
-47.78 %-84.28%
-303.91 %+169.83%
-112.63 %-81.15%
-597.40 %+167.89%
-223.00 %-68.44%
-706.52 %+506.55%
-116.48 %-178.05%
149.24 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axe Compute Stock analysis

What does Axe Compute do? Predictive Oncology, Inc. generates revenue through its subsidiaries Helomics Holding Corporation and Skyline Medical Inc. Helomics applies artificial intelligence to patient tumor data to personalize cancer therapies and develop new-targeted therapies, offering CLIA-certified clinical testing for oncologists. Skyline Medical Inc. markets the STREAMWAY System, which automates medical fluid disposal, targeting hospitals and clinics globally. The company's products serve healthcare providers seeking advanced diagnostic and waste management solutions. Helomics focuses on personalized cancer treatment decisions using AI-driven analysis, while Skyline Medical Inc. provides automated fluid disposal systems. The STREAMWAY System is sold through domestic and international divisions to medical facilities requiring efficient waste handling. TumorGenesis Inc. supports laboratory-based tumor research, complementing Helomics' clinical offerings. The company's revenue streams include AI-based therapy personalization services and the STREAMWAY System sales. Healthcare providers, including oncologists and medical facilities, purchase these products to enhance treatment precision and operational efficiency. Subsidiaries operate under the parent company's structure, with Helomics handling AI applications and Skyline Medical managing medical device distribution. Axe Compute is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axe Compute stock

Return on Invested Capital (ROIC) of Axe Compute is -472.01 % in 2025.

Return on Invested Capital (ROIC) of Axe Compute changed from -632.72 % to -472.01 %, representing a -25.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Axe Compute since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Axe Compute with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Axe Compute

All Key Metrics — Axe Compute